Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
When comparing patients who initiated treatment with exenatide (n=14,076, median follow-up: 969 days), to those starting dulaglutide (n=54,787, median follow-up: 948 days) or liraglutide (n=25,562, median follow-up: 1,007 days), no differences were found in the hazard of composite treatment for diabetic macular edema (DME) and/or proliferative DR: exenatide vs
Therapeutic drug monitoring is not required or available for most anticonvulsants
Retrieved from Vignini, A., Borroni, F., Sabbatinelli, J., et al
It acts on GLP-1, GIP, and glucagon receptors, which makes it more comprehensive in its approach compared to Semaglutide, which focuses only on GLP-1
Consult your healthcare provider about which option fits your needs
.jpg)
